CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Solta Medical Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Solta Medical Inc
25881 Industrial Boulevard
Phone: (510) 782-2286p:510 782-2286 HAYWARD, CA  94545  United States Fax: (510) 786-6895f:510 786-6895
This company ceased filing statements with the SEC on 2/3/2014.
This company is no longer actively traded on any major stock exchange.
This is a Subsidiary, click here for the Parent Company
Business Summary
Solta Medical, Inc. designs, develops, manufactures and markets professional and consumer energy-based medical device systems for aesthetic applications. The Company's systems are cleared by the United States Food and Drug Administration (FDA) for dermatological procedures performed in the physician led, professional assist, and personal care markets. The Company’s portfolio of products includes six brands that are primarily designed for aesthetic applications: The Fraxel re:pair system provides ablative laser skin resurfacing while the non-ablative Fraxel platform and Clear + Brilliant systems provide treatment for skin rejuvenation. The Thermage system provides non-invasive skin tightening and the Liposonix system provides non-invasive body contouring. Isolaz and CLARO provide options to resolve acne. In January 2014, Valeant Pharmaceuticals International Inc 's wholly-owned subsidiary Valeant Pharmaceuticals International acquired Solta Medical Inc.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/201312/31/2012YesYes--Yes

Industries
SIC Code Description
3845 Electromedical and electrotherapeutic apparatus
5047 Medical, dental, and hospital equipment and supplies
3841 Surgical and medical instruments and apparatus

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, Interim President, Interim Chief Executive Officer Mark M.Sieczkarek 58 8/6/2013 7/1/2006
Chief Financial Officer John F.Glenn 51 1/3/2008 1/3/2008
Vice President - Finance H. DanielFerrari 54 7/1/2009 1/3/2008
9 additional Officers and Directors records available in full report.

Business Names
Business Name
Aesthera Corporation
CLRS Technology Corporation
Liposonix, Inc.
12 additional Business Names available in full report.

General Information
Number of Employees: 371 (As of 12/31/2012)
Outstanding Shares: 80,739,760 (As of 10/31/2013)
Shareholders: 4,740
Stock Exchange: NASD
Federal Tax Id: 680373593
Fax Number: (510) 786-6895
Email Address: info@thermage.com


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023